FDA: Fresenius Kabi recalls sodium chloride injection

Editor's Note

The Food and Drug Administration (FDA) on November 20 announced the nationwide recall by Fresenius Kabi USA (Lake Zurich, Illinois) of 163 lots of sodium chloride injection, USP, 0.9%, 10 mL and 20 mL vials.

The recall was initiated because the product insert incorrectly states that the vial stoppers do not contain latex. The stoppers do contain natural rubber latex, which could cause an anaphylactic reaction in those with a severe allergy to latex.

The company has not received any reports of adverse events related to the recall.